Skip to main content

Advertisement

Table 2 Patient characteristics (n = 261)

From: Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes

Characteristics   
Age (years)   
 Median 73  
 Mean 72.2  
 Range 50–85  
Follow-up   
 Median (months) 61.6  
  n %
Tumor stage   
  ≤ T1c, T2a 163 62.5
 T2b–T2c 63 24.1
  ≥ T3a 35 13.4
Gleason score   
  ≤ 6 79 30.3
 7 101 38.7
 8–10 81 31.0
PSA   
  ≤ 10 123 47.1
 10–20 67 25.7
 20< 71 27.2
NCCN risk group   
 Low risk 42 16.1
 Intermediate risk 95 36.4
 High risk 124 47.5
Prescribed dose (Gy)  
 78 22 8.4
 80 52 19.9
 82 80 30.7
 84 85 32.6
 86 22 8.4
Hormonal therapy   
 (+) 193 73.9
 (−) 68 26.1
  1. NCCN national comprehensive cancer network, PSA prostate specific antigen